Drug intelligence / Profile preview

ethyl linoleate (Guizhou Univ. of Traditional Chinese Medicine)

Development stage: Preclinical
Lead developer: Guizhou University of Traditional Chinese Medicine

Overview

ethyl linoleate (Guizhou Univ. of Traditional Chinese Medicine): sourced facts only. name: "Network pharmacology analysis revealed that ethyl linoleate (EL), a key component of JJC, targeted DKK1." [PMID:40808343]; target: "Network pharmacology analysis revealed that ethyl linoleate (EL), a key component of JJC, targeted DKK1." [PMID:40808343]; developer: "Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, China." [PMID:40808343]; stage: "RA model rats showed a dose-dependent response to EL." [PMID:40808343]

Targets

DKK1 (Dickkopf-related protein 1)

Beyond the preview

Go deeper on ethyl linoleate (Guizhou Univ. of Traditional Chinese Medicine).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethyl linoleate (Guizhou Univ. of Traditional Chinese Medicine).